Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma (Q36368072)

13 August 2017

Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma (English)

1 reference

13 August 2017

1 reference

1 reference

7

Kjersti Flatmark

1 reference

13 August 2017

2

Anne Hansen Ree

1 reference

13 August 2017

1

Marie Grøn Saelen

1 reference

13 August 2017

Helga Helseth Hektoen

series ordinal

6

object named as

Helga Helseth Hektoen

1 reference

13 August 2017

Karianne Giller Fleten

series ordinal

4

object named as

Karianne Giller Fleten

1 reference

13 August 2017

5

Torbjørn Furre

1 reference

13 August 2017

Alexandr Kristian

3

1 reference

13 August 2017

27 September 2012

1 reference

13 August 2017

1 reference

13 August 2017

7

1 reference

13 August 2017

165

1 reference

https://scigraph.springernature.com/pub.10.1186/1748-717x-7-165

13 August 2017

0 references

cites work

Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Retention of the in vitro radiosensitizing potential of gemcitabine under anoxic conditions, in p53 wild-type and p53-deficient non-small-cell lung carcinoma cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Molecular targeted treatment and radiation therapy for rectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Influence of irinotecan and SN-38 on the irradiation response of WHO3 human oesophageal tumour cells under hypoxic conditions.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Should tumors be clamped in radiobiological fractionation experiments?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488009

Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials

30 September 2017

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-165

Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-165

Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-165

Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-165

Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-165

Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-7-165

Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation

21 January 2018

1 reference

12 December 2020

Rectal cancer trials: no movement

1 reference

12 December 2020

Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging

1 reference

12 December 2020

Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers

1 reference

12 December 2020

Identifiers

DOI

10.1186/1748-717X-7-165

1 reference

Dimensions Publication ID

13 August 2017

0 references

1 reference

13 August 2017

1 reference